SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-136873
Filing Date
2022-05-02
Accepted
2022-05-02 16:38:19
Documents
14
Period of Report
2022-05-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d232899d8k.htm   iXBRL 8-K 25638
2 EX-99.1 d232899dex991.htm EX-99.1 20780
6 GRAPHIC g232899dsp1.jpg GRAPHIC 11105
  Complete submission text file 0001193125-22-136873.txt   194518

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA caba-20220502.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20220502_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20220502_pre.xml EX-101.PRE 11718
8 EXTRACTED XBRL INSTANCE DOCUMENT d232899d8k_htm.xml XML 3468
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 22882593
SIC: 2836 Biological Products, (No Diagnostic Substances)